2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study - Wikidata - awgldk - TriplyDB

2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study

2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study

http://www.wikidata.org/entity/Q33837666

about

A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study.In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis.Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity.

P2860

Q36395993-B247CA00-99F9-40A4-8214-72EB26598AB6 Q36778047-4D9B3153-007D-4A1D-8E5F-7D5541685943 Q38778339-74623E5E-67F8-4310-8B50-D25715E7C976 Q39107517-1DDAF018-1C1A-4458-BDB1-258FDA68A304 Q39386461-ADF4B0D8-DE73-4933-8AEF-362CF3B2F997 Q40746044-333A8443-CD23-4C77-8A33-EF3272CC82EF Q52665633-30CBAE71-9267-40CF-B16B-ED6BAAAEFF64

P2860

2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study

http://www.wikidata.org/entity/Q33837666

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@ast

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@en

type

label

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@ast

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@en

prefLabel

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@ast

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@en

P1433

Q33837666-3E6AF2C5-9174-4CDF-B808-85F58216B69C

P1476

Q33837666-B2B95741-DDF5-4CCE-8285-52BE23C0F153

P2093

Q33837666-14EE18AF-8EB7-4B47-9B8B-B215412B2BCF

Q33837666-4AA543AF-84E1-4B5E-B556-EF32E1460375

Q33837666-63BDF77C-147A-46F4-B5C2-3BA240800B84

Q33837666-7FB1D096-27AB-400D-ACCF-B9A71594859D

Q33837666-D65B9822-D30C-4F75-AB0C-6AB953B1E299

P2860

Q33837666-1440C523-B440-479F-875E-D9EF1749CB52

Q33837666-1D32DC9C-918B-4E5C-BE45-826D61815A4F

Q33837666-26572210-C97E-4243-8AA1-6D07C8BD8184

Q33837666-2D7F6ABA-6982-417B-8D0A-03261127CD61

Q33837666-3432EB14-A615-402D-8FF6-362A1DD699E5

Q33837666-4CAABF8F-0A3E-4823-B57D-42F36BE16177

Q33837666-4FAD2A21-D0F0-4ED6-A9D4-762E6DA44716

Q33837666-84331CAE-25AD-4747-A461-AC9E1842A91D

Q33837666-BDBEAA79-7D6B-4B2F-918C-2A4FCB18B945

Q33837666-D0024634-9EE5-4AA0-BF57-D006CBB55A9A

P304

Q33837666-FC6D8F3C-F6C1-41F0-91E8-0DADECE1FC35

P31

Q33837666-853EB04E-26EA-4863-8F25-0418DDC382AA

P356

Q33837666-03FEBC87-AA5F-49AE-8B1F-AFC7ADCC9D47

P407

Q33837666-175A9957-E7EF-44B9-B479-0314B6FE2999

P433

Q33837666-2563FB67-0A6B-4273-9CBD-57BDD81F6F8D

P478

Q33837666-E8578AD8-7C4F-40AB-90D9-80D77D9A6EA9

P50

Q33837666-845EBD26-8C1C-4956-B4E7-13FF994B596C

P577

Q33837666-A7F0D812-6C92-4414-BD37-AAE5AC31B2E7

P5875

Q33837666-FD86AEE2-ED25-4437-83D4-B0A685E75740

P698

Q33837666-EFE239E9-9B3A-47BD-AC35-E458E2B1200E

P932

Q33837666-C84ED210-D925-44EA-8D26-C5E931BF3E58

P356

J.BMCL.2011.02.055

P1433

Bioorganic & Medicinal Chemistry Letters

P1476

2,3-Substituted quinoxalin-6-a ...... re-activity relationship study

@en

P2093

David L Kelly

http://www.w3.org/2001/XMLSchema#string

Hernando Lopez

http://www.w3.org/2001/XMLSchema#string

Qianyi Chen

http://www.w3.org/2001/XMLSchema#string

Vashti C Bryant

http://www.w3.org/2001/XMLSchema#string

Xu Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Privileged scaffolds for library design and drug discovery

High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation.

Dual-fluorophore quantitative high-throughput screen for inhibitors of BRCT-phosphoprotein interaction

Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.

High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions.

Perturbation of the Bcl-2 network and an induced Noxa/Bcl-xL interaction trigger mitochondrial dysfunction after DNA damage

The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.

Structural characterization of BRCT-tetrapeptide binding interactions.

Synthesis and biological activities of pyrazolo[3,4-g]quinoxaline derivatives.

A synopsis of recent developments in antiglaucoma drugs.

P304

1929-1932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2011.02.055

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Amarnath Natarajan

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50287781

http://www.w3.org/2001/XMLSchema#string

P698

21376584

http://www.w3.org/2001/XMLSchema#string

P932

3063321

http://www.w3.org/2001/XMLSchema#string